Exploring Beta-sitosterol’s Role in Breast Cancer Treatment via Integrated Network Pharmacological Analysis and in vitro Validation

ABSTRACT

Background: Beta-sitosterol, a phytosterol similar to cholesterol, is found in various plants and is recognized for its potential anticancer properties; still, the mechanism of breast cancer (BC) remains elusive. Objectives: This study investigates the potential targets of beta-sitosterol in BC using network pharmacological analysis and in vitro validation. Materials and Methods: Targets of beta-sitosterol and BC were identified from online databases, including Swiss Target Prediction, SuperPred, GeneCards, and DisGeNET. Protein–protein interactions of common targets were analyzed using STRING version 11.0, and network construction and core target screening were performed with Cytoscape 3.8.0. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and gene ontology (GO) annotation were conducted using the ShinyGO web tool. Molecular docking analysis was done with AutoDock Vina and the in vitro validation, including cell viability, apoptosis, and gene expression analysis was done using MTT assay, acridine orange/ethidium bromide staining, and polymerase chain reaction (PCR), respectively. Results: Sixty-eight common targets for beta-sitosterol and BC were identified from 209 beta-sitosterol targets and 1,350 BC-related genes. Five core targets (HIF1A, ESR1, STAT3, TNF, and MAPK3) were identified. GO analysis linked common targets to biological processes, cellular components, and molecular functions. KEGG pathway analysis showed enrichment in pathways such as central carbon metabolism in cancer, vascular endothelial growth factor signaling, and prolactin signaling. Beta-sitosterol’s impact on MCF7 cell viability was assessed via MTT assay, and its molecular effects were explored through PCR. Results demonstrated beta-sitosterol’s ability to hinder tumor progression by modulating genes involved in ESR1, mitogen-activated protein kinase, and tumor necrosis factor signaling pathways. Conclusion: These findings highlight beta-sitosterol’s potential as an anticancer agent, offering new perspectives for clinical investigations through the modulation of key signaling pathways in BC.

KEYWORDS

• Breast cancer
• beta-sitosterol
• pathway enrichment analysis
• gene expression
• cell viability

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241294143Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 21, ISSUE 4Reserpine Ameliorates 1,2-Dimethylhydrazineinduced Colon Cancer through Regulating Xenobiotic Enzymes and Bax/Caspases/Bcl2-mediated Apoptotic Mechanisms in RatsWenli He, Lina He · pp. 1165–1175Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 4Study on the Neuroprotective Mechanism of Salidroside Modified with Polydopamine Nanoparticles in Regulating Notch Pathway by Inhibiting miR-155 in Stroke Ratsactivity of AQP, TLR TLR, Song Liu, Xiaomeng Lv, Dong Wang · pp. 1176–1186Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 4Artemetin Inhibits Cell Growth and Activates Caspase-dependent Apoptotic Cell Death Colon Cancer HCT-116 CellsYan Chen, Lu Men · pp. 1212–1219Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 4Protective Effect of 1,8-Cineole (Eucalyptol) on Respiratory System: A Systematic Review and Meta-analysis from Animal StudiesJie Liu, Xingde Liu, Xiaoman Xiong, Yuhua Zheng, Rui Rao, Wen Li · pp. 1220–1230Original Research ArticleSame type: Article